SEC Form 4 · accession 0001600132-19-000042
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan M Peacock
Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2019 | A | 227,273 | $0.00 | A | 1,141,634 | D |
Table II — derivative securities
No Table II lines on this filing.